Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
2 Biotech Stocks That Could Make You Richer
02:07pm, Saturday, 17'th Sep 2022 The Motley Fool
Both have performed better than the broader market this year, but one stands out in this category.
Is It Too Late to Buy Axsome Therapeutics Stock?
10:30am, Saturday, 17'th Sep 2022 The Motley Fool
The company's revenue story is just starting.
2 Biotech Stocks That Could Make You Richer
10:07am, Saturday, 17'th Sep 2022
Both have performed better than the broader market this year, but one stands out in this category.
Is It Too Late to Buy Axsome Therapeutics Stock?
06:30am, Saturday, 17'th Sep 2022
The company's revenue story is just starting.
Axsome: In The Middle Of Uncertainty Is Your Biggest Opportunity
01:31pm, Friday, 16'th Sep 2022
For over a year, Axsome Therapeutics suffered substantial share price depreciation due to the uncertain fate of its lead medicine (AXS05). Like the cream that always rises to the top, AXS05 recently g
7 Top-Rated Biotech Stocks to Buy for Q4
03:00pm, Thursday, 15'th Sep 2022
A new White House program will likely boost the entire biotech industry. And it makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
3 Top Healthcare Stocks Defying the Bear Market
10:00am, Thursday, 15'th Sep 2022 The Motley Fool
There's reason to favor these stocks -- and hold on for the long term.
3 Top Healthcare Stocks Defying the Bear Market
06:00am, Thursday, 15'th Sep 2022
There's reason to favor these stocks -- and hold on for the long term.
Axsome Therapeutics to Present at the Cowen 2nd Annual Novel Mechanisms in Neuropsychiatry Summit
07:00am, Wednesday, 14'th Sep 2022
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syste
3 Growth Stocks That Are Crushing It This Year
02:45pm, Saturday, 10'th Sep 2022 The Motley Fool
These three biotech companies have bucked the trend of declining shares prices in their sector.
2 Top Biotech Stocks Defying the Bear Market
02:30pm, Saturday, 10'th Sep 2022 The Motley Fool
Both could see record sales throughout the next few years.
3 Growth Stocks That Are Crushing It This Year
10:45am, Saturday, 10'th Sep 2022
These three biotech companies have bucked the trend of declining shares prices in their sector.
2 Top Biotech Stocks Defying the Bear Market
10:30am, Saturday, 10'th Sep 2022
Both could see record sales throughout the next few years.
Axsome (AXSM) Initiates Late-Stage Alzheimer's Agitation Study
04:18pm, Friday, 09'th Sep 2022 Zacks Investment Research
Axsome Therapeutics (AXSM) enrolls the first patient in a late-stage study of AXS-05 for Alzheimer's disease agitation.
Is Axsome Therapeutics a Buy?
02:53pm, Friday, 09'th Sep 2022 The Motley Fool
Its near-term outlook is quite rosy, but there is also a risk it might not meet investors' hopes.
